Efficacy and safety of triple combination therapy with transarterial chemoembolization (TACE), tyrosine kinase inhibitor (TKI), and immune checkpoint inhibitor (ICI) versus dual combination therapy in unresectable hepatocellular carcinoma (uHCC): A systematic review and meta-analysis

被引：0
|
作者：
Maano, O. P. [1 ]
Malbas, J. M. V. [1 ]
Dy, C. [1 ]
机构：
[1] St Lukes Med Ctr Quezon City, Canc Inst, Quezon City, Philippines
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.2147
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1003P
引用
收藏
页码：S614 / S614
页数：1
相关论文
共 50 条
  • [31] Clinical Efficacy and Safety of an Immune Checkpoint Inhibitor in Combination with Regorafenib Therapy as Second-Line Regimen for Patients with Unresectable Hepatocellular Carcinoma
    Li, Jinpeng
    Jia, Yuntao
    Shao, Changdong
    Li, Yuanming
    Song, Jinlong
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2023, 19 : 329 - 339
  • [32] Comparison of the Impact of Immune-Related Adverse Events Due to Immune Checkpoint Inhibitor Dual Combination Therapy and Immune Checkpoint Inhibitor Plus Tyrosine Kinase Inhibitor Combination Therapy in Patients with Advanced Renal Cell Carcinoma
    Hiroki Ishihara
    Yuki Nemoto
    Kazutaka Nakamura
    Hidekazu Tachibana
    Hironori Fukuda
    Kazuhiko Yoshida
    Hirohito Kobayashi
    Junpei Iizuka
    Hiroaki Shimmura
    Yasunobu Hashimoto
    Tsunenori Kondo
    Toshio Takagi
    Targeted Oncology, 2023, 18 : 159 - 168
  • [33] Comparison of the Impact of Immune-Related Adverse Events Due to Immune Checkpoint Inhibitor Dual Combination Therapy and Immune Checkpoint Inhibitor Plus Tyrosine Kinase Inhibitor Combination Therapy in Patients with Advanced Renal Cell Carcinoma
    Ishihara, Hiroki
    Nemoto, Yuki
    Nakamura, Kazutaka
    Tachibana, Hidekazu
    Fukuda, Hironori
    Yoshida, Kazuhiko
    Kobayashi, Hirohito
    Iizuka, Junpei
    Shimmura, Hiroaki
    Hashimoto, Yasunobu
    Kondo, Tsunenori
    Takagi, Toshio
    TARGETED ONCOLOGY, 2023, 18 (01) : 159 - 168
  • [34] Efficacy and safety of preoperative transarterial chemoembolization for hepatocellular carcinoma: a systematic review and meta-analysis
    Mi, Shizheng
    Nie, Yang
    Xie, Changming
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2022, 57 (09) : 1070 - 1079
  • [35] A Systematic Review of Treatment-Related Adverse Events for Combination Therapy of Multiple Tyrosine Kinase Inhibitor and Immune Checkpoint Inhibitor
    Sawada, Takashi
    Narukawa, Mamoru
    CANCER CONTROL, 2024, 31
  • [36] Transarterial chemoembolization combined with lenvatinib versus transarterial chemoembolization combined with sorafenib for unresectable hepatocellular carcinoma: A systematic review and meta-analysis
    Liu, Jun-Ning
    Li, Ji-Jiang
    Yan, Shu
    Zhang, Guang-Nian
    Yi, Peng-Sheng
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [37] Transarterial chemoembolization combined with lenvatinib versus transarterial chemoembolization combined with sorafenib for unresectable hepatocellular carcinoma: A meta-analysis and systematic review
    Che, X.
    Zhang, W.
    Yin, Y.
    ANNALS OF ONCOLOGY, 2024, 35 : S80 - S80
  • [38] Efficacy and Safety of PARP Inhibitor Combination Therapy in Recurrent Ovarian Cancer: A Systematic Review and Meta-Analysis
    Ren, Ning
    Zhang, Leyin
    Yu, Jieru
    Guan, Siqi
    Dai, Xinyang
    Sun, Leitao
    Ying, Minli
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [39] The efficacy of transarterial chemoembolization combined with microwave ablation for unresectable hepatocellular carcinoma: a systematic review and meta-analysis
    Wang, Lei
    Ke, Qiao
    Lin, Nanping
    Huang, Qizhen
    Zeng, Yongyi
    Liu, Jingfeng
    INTERNATIONAL JOURNAL OF HYPERTHERMIA, 2019, 36 (01) : 1287 - 1295
  • [40] Immune checkpoint inhibitor (ICI) combination therapy compared to monotherapy in advanced solid cancer: A systematic review
    Ma, Xiaoting
    Zhang, Yujian
    Wang, Shan
    Wei, Huamin
    Yu, Jing
    JOURNAL OF CANCER, 2021, 12 (05): : 1318 - 1333
12345